Trials / Sponsors / Elpida Therapeutics SPC
Elpida Therapeutics SPC
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) Charcot-Marie-Tooth Disease Type 4J | Phase 1 / Phase 2 | 2026-04-01 |
| Recruiting | Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls. Hereditary Spastic Paraplegia Type 50 | Phase 3 | 2026-02-01 |
| Recruiting | A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J Peripheral Neuropathy, Neuro-Degenerative Disease, Neuromuscular Diseases | — | 2024-07-29 |
| Recruiting | Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP Spasticity, Muscle, Microcephaly, Intellectual Deficiency | Phase 1 / Phase 2 | 2023-02-15 |